CLINICAL_TRIALS
trial_result
· 2022-02-24
Clinical Trial Update: Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics [Phase 3]
Summary
Phase 3 chronic-dose safety and efficacy study of Albuterol-HFA-BAI in pediatric asthmatics completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2022-02-24